Skip to main content
. 2009 Dec 11;115(7):1343–1350. doi: 10.1182/blood-2009-08-239046

Table 2.

Second-line salvage regimens

Regimen thal/dex (n = 139), n (%) len/dex (n = 97), n (%) P
Transplantation 14 (10.1) 18 (18.6) .061
Bortezomib-based regimen 21 (15.1) 28 (28.9) .014
Lenalidomide-based regimen 34 (24.5) 22 (22.7) .752
Lenalidomide-bortezomib based regimen 0 (0) 4 (4.1) .028
Thalidomide-based regimen 23 (16.6) 10 (10.3) .174
Others 47 (33.8) 15 (15.5) .002